Highline Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1K | Buy |
498
+23
| +5% | +$883 | 0.01% | 231 |
|
|
2025
Q1 | $18.4K | Buy |
475
+428
| +911% | +$16.6K | 0.01% | 215 |
|
|
2024
Q4 | $1.59K | Buy |
47
+7
| +18% | +$237 | ﹤0.01% | 480 |
|
|
2024
Q3 | $1.64K | Sell |
40
-54
| -57% | -$2.21K | ﹤0.01% | 468 |
|
|
2024
Q2 | $3.62K | Buy |
+94
| New | +$3.62K | ﹤0.01% | 317 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 437 |
|
|
2023
Q4 | – | Sell |
-20
| Closed | -$725 | – | 420 |
|
|
2023
Q3 | $725 | Buy |
+20
| New | +$725 | ﹤0.01% | 332 |
|